These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 35290538)

  • 21. A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing Cytokine Storm and Virus in SARS-CoV-2 Infection.
    Ahmed F
    Front Immunol; 2020; 11():590459. PubMed ID: 33362771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential gene expression profiling reveals potential biomarkers and pharmacological compounds against SARS-CoV-2: Insights from machine learning and bioinformatics approaches.
    Hoque MN; Sarkar MMH; Khan MA; Hossain MA; Hasan MI; Rahman MH; Habib MA; Akter S; Banu TA; Goswami B; Jahan I; Nafisa T; Molla MMA; Soliman ME; Araf Y; Khan MS; Zheng C; Islam T
    Front Immunol; 2022; 13():918692. PubMed ID: 36059456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding SARS-CoV-2 endocytosis for COVID-19 drug repurposing.
    Glebov OO
    FEBS J; 2020 Sep; 287(17):3664-3671. PubMed ID: 32428379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Weighted Gene Co-Expression Network Analysis Combined with Machine Learning Validation to Identify Key Modules and Hub Genes Associated with SARS-CoV-2 Infection.
    Karami H; Derakhshani A; Ghasemigol M; Fereidouni M; Miri-Moghaddam E; Baradaran B; Tabrizi NJ; Najafi S; Solimando AG; Marsh LM; Silvestris N; De Summa S; Paradiso AV; Racanelli V; Safarpour H
    J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34441862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood transcriptome analysis revealed the crosstalk between COVID-19 and HIV.
    Yan C; Niu Y; Wang X
    Front Immunol; 2022; 13():1008653. PubMed ID: 36389792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicted SARS-CoV-2 miRNAs Associated with Epigenetic Viral Pathogenesis and the Detection of New Possible Drugs for Covid-19.
    Çetin Z; Bayrak T; Oğul H; Saygılı Eİ; Akkol EK
    Curr Drug Deliv; 2021; 18(10):1595-1610. PubMed ID: 33645482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrative multiomics and in silico analysis revealed the role of ARHGEF1 and its screened antagonist in mild and severe COVID-19 patients.
    Jha P; Singh P; Arora S; Sultan A; Nayek A; Ponnusamy K; Syed MA; Dohare R; Chopra M
    J Cell Biochem; 2022 Mar; 123(3):673-690. PubMed ID: 35037717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multi-stage virtual screening of FDA-approved drugs reveals potential inhibitors of SARS-CoV-2 main protease.
    Mandour YM; Zlotos DP; Alaraby Salem M
    J Biomol Struct Dyn; 2022 Mar; 40(5):2327-2338. PubMed ID: 33094680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repurposing potential of FDA-approved and investigational drugs for COVID-19 targeting SARS-CoV-2 spike and main protease and validation by machine learning algorithm.
    Verma AK; Aggarwal R
    Chem Biol Drug Des; 2021 Apr; 97(4):836-853. PubMed ID: 33289334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Candidate COVID-19 Therapeutics using hPSC-derived Lung Organoids.
    Han Y; Yang L; Duan X; Duan F; Nilsson-Payant BE; Yaron TM; Wang P; Tang X; Zhang T; Zhao Z; Bram Y; Redmond D; Houghton S; Nguyen D; Xu D; Wang X; Uhl S; Huang Y; Johnson JL; Xiang J; Wang H; Pan FC; Cantley LC; tenOever BR; Ho DD; Evans T; Schwartz RE; Chen HJ; Chen S
    bioRxiv; 2020 May; ():. PubMed ID: 32511403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin.
    Qian Y; Lei T; Patel PS; Lee CH; Monaghan-Nichols P; Xin HB; Qiu J; Fu M
    J Virol; 2021 Nov; 95(23):e0139621. PubMed ID: 34549987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Host transcriptome-guided drug repurposing for COVID-19 treatment: a meta-analysis based approach.
    Loganathan T; Ramachandran S; Shankaran P; Nagarajan D; Mohan S S
    PeerJ; 2020; 8():e9357. PubMed ID: 32566414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2 research using human pluripotent stem cells and organoids.
    Deguchi S; Serrano-Aroca Á; Tambuwala MM; Uhal BD; Brufsky AM; Takayama K
    Stem Cells Transl Med; 2021 Nov; 10(11):1491-1499. PubMed ID: 34302450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification.
    Li Y; Chu F; Li P; Johnson N; Li T; Wang Y; An R; Wu D; Chen J; Su Z; Gu X; Ding X
    J Ethnopharmacol; 2021 May; 271():113854. PubMed ID: 33513419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioinformatics analyses of significant genes, related pathways, and candidate diagnostic biomarkers and molecular targets in SARS-CoV-2/COVID-19.
    Vastrad B; Vastrad C; Tengli A
    Gene Rep; 2020 Dec; 21():100956. PubMed ID: 33553808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of hub genes associated with COVID-19 and idiopathic pulmonary fibrosis by integrated bioinformatics analysis.
    Chen Q; Xia S; Sui H; Shi X; Huang B; Wang T
    PLoS One; 2022; 17(1):e0262737. PubMed ID: 35045126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel therapeutic targets for SARS-CoV-2-induced acute lung injury: Targeting a potential IL-1β/neutrophil extracellular traps feedback loop.
    Yaqinuddin A; Kashir J
    Med Hypotheses; 2020 Oct; 143():109906. PubMed ID: 32505910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting hub genes and pathways of innate immune response in COVID-19: A network biology perspective.
    Prasad K; Khatoon F; Rashid S; Ali N; AlAsmari AF; Ahmed MZ; Alqahtani AS; Alqahtani MS; Kumar V
    Int J Biol Macromol; 2020 Nov; 163():1-8. PubMed ID: 32599245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elucidating the Drug Repurposing Spectra of COVID-19 with its Analogues SARS and MERS.
    Mishra J; Prasun C; Sahoo PK; Nair MS
    Mini Rev Med Chem; 2021; 21(20):3191-3202. PubMed ID: 33632095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrative transcriptomics analysis of lung epithelial cells and identification of repurposable drug candidates for COVID-19.
    Islam T; Rahman MR; Aydin B; Beklen H; Arga KY; Shahjaman M
    Eur J Pharmacol; 2020 Nov; 887():173594. PubMed ID: 32971089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.